Skip to main content
eScholarship
Open Access Publications from the University of California

ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and the Cancer Genome Atlas

  • Author(s): Johnatty, SE
  • Beesley, J
  • Gao, B
  • Chen, X
  • Lu, Y
  • Law, MH
  • Henderson, MJ
  • Russell, AJ
  • Hedditch, EL
  • Emmanuel, C
  • Fereday, S
  • Webb, PM
  • Goode, EL
  • Vierkant, RA
  • Fridley, BL
  • Cunningham, JM
  • Fasching, PA
  • Beckmann, MW
  • Ekici, AB
  • Hogdall, E
  • Kjaer, SK
  • Jensen, A
  • Hogdall, C
  • Brown, R
  • Paul, J
  • Lambrechts, S
  • Despierre, E
  • Vergote, I
  • Lester, J
  • Karlan, BY
  • Heitz, F
  • Du Bois, A
  • Harter, P
  • Schwaab, I
  • Bean, Y
  • Pejovic, T
  • Levine, DA
  • Goodman, MT
  • Camey, ME
  • Thompson, PJ
  • Lurie, G
  • Shildkraut, J
  • Berchuck, A
  • Terry, KL
  • Cramer, DW
  • Norris, MD
  • Haber, M
  • MacGregor, S
  • DeFazio, A
  • Chenevix-Trench, G
  • et al.

Published Web Location

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795832/
No data is associated with this publication.
Abstract

Objective. ABCB1 encodes the multi-drug efflux pump P-glycoprotein (P-gp) and has been implicated in multi-drug resistance.We comprehensively evaluated this gene and flanking regions for an associationwith clinical outcome in epithelial ovarian cancer (EOC). Methods. The best candidates from fine-mapping analysis of 21 ABCB1 SNPs tagging C1236T (rs1128503), G2677T/A (rs2032582), and C3435T (rs1045642) were analysed in 4616 European invasive EOC patients from thirteen Ovarian Cancer Association Consortium(OCAC) studies and The Cancer Genome Atlas (TCGA). Additionally we analysed 1,562 imputed SNPs around ABCB1 in patients receiving cytoreductive surgery and either 'standard' first-line paclitaxel-carboplatin chemotherapy (n = 1158) or any first-line chemotherapy regimen (n = 2867). We also evaluated ABCB1 expression in primary tumours from 143 EOC patients. Result. Fine-mapping revealed that rs1128503, rs2032582, and rs1045642were the best candidates in optimally debulked patients. However, we observed no significant association between any SNP and either progression-free survivaloroverall survival inanalysis ofdata from14 studies. There was a marginal association between rs1128503 and overall survival in patients with nil residual disease (HR 0.88, 95% CI 0.77-1.01; p = 0.07). In contrast, ABCB1 expression in the primary tumour may confer worse prognosis in patients with sub-optimally debulked tumours. Conclusion. Our study represents the largest analysis of ABCB1 SNPs and EOC progression and survival to date, but has not identified additional signals, or validated reported associations with progression-free survival for rs1128503, rs2032582, and rs1045642. However, we cannot rule out the possibility of a subtle effect of rs1128503, or other SNPs linked to it, on overall survival. © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item